PL366644A1 - Nowy związek, zastosowanie nowego związku w leczeniu chorób neurologicznych oraz sposób otrzymywania nowego związku - Google Patents

Nowy związek, zastosowanie nowego związku w leczeniu chorób neurologicznych oraz sposób otrzymywania nowego związku

Info

Publication number
PL366644A1
PL366644A1 PL04366644A PL36664404A PL366644A1 PL 366644 A1 PL366644 A1 PL 366644A1 PL 04366644 A PL04366644 A PL 04366644A PL 36664404 A PL36664404 A PL 36664404A PL 366644 A1 PL366644 A1 PL 366644A1
Authority
PL
Poland
Prior art keywords
new compound
therapy
obtaining
well
application
Prior art date
Application number
PL04366644A
Other languages
English (en)
Other versions
PL204750B1 (pl
Inventor
Andrzej Niewiadomy
Joanna Matysiak
Wojciech Rzeski
Original Assignee
Akademia Rolnicza
Uniwersytet Marii Curie Skłodowskiej
Andrzej Niewiadomy
Joanna Matysiak
Wojciech Rzeski
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akademia Rolnicza, Uniwersytet Marii Curie Skłodowskiej, Andrzej Niewiadomy, Joanna Matysiak, Wojciech Rzeski filed Critical Akademia Rolnicza
Priority to PL366644A priority Critical patent/PL204750B1/pl
Priority to PCT/PL2005/000019 priority patent/WO2005092873A2/en
Publication of PL366644A1 publication Critical patent/PL366644A1/pl
Publication of PL204750B1 publication Critical patent/PL204750B1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01—Five-membered rings
    • C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/12—1,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles
    • C07D285/125—1,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles with oxygen, sulfur or nitrogen atoms, directly attached to ring carbon atoms, the nitrogen atoms not forming part of a nitro radical
    • C07D285/135—Nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
PL366644A 2004-03-26 2004-03-26 Pochodna 1,3,4-tiadiazolu , zastosowanie pochodnej 1,3,4-tiadiazolu w leczeniu chorób neurologicznych oraz sposób otrzymywania pochodnej 1,3,4-tiadiazolu PL204750B1 (pl)

Priority Applications (2)

Application Number Priority Date Filing Date Title
PL366644A PL204750B1 (pl) 2004-03-26 2004-03-26 Pochodna 1,3,4-tiadiazolu , zastosowanie pochodnej 1,3,4-tiadiazolu w leczeniu chorób neurologicznych oraz sposób otrzymywania pochodnej 1,3,4-tiadiazolu
PCT/PL2005/000019 WO2005092873A2 (en) 2004-03-26 2005-03-25 Thiadiazoles for treatment of cancer or neurological disease

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL366644A PL204750B1 (pl) 2004-03-26 2004-03-26 Pochodna 1,3,4-tiadiazolu , zastosowanie pochodnej 1,3,4-tiadiazolu w leczeniu chorób neurologicznych oraz sposób otrzymywania pochodnej 1,3,4-tiadiazolu

Publications (2)

Publication Number Publication Date
PL366644A1 true PL366644A1 (pl) 2005-10-03
PL204750B1 PL204750B1 (pl) 2010-02-26

Family

ID=35056781

Family Applications (1)

Application Number Title Priority Date Filing Date
PL366644A PL204750B1 (pl) 2004-03-26 2004-03-26 Pochodna 1,3,4-tiadiazolu , zastosowanie pochodnej 1,3,4-tiadiazolu w leczeniu chorób neurologicznych oraz sposób otrzymywania pochodnej 1,3,4-tiadiazolu

Country Status (2)

Country Link
PL (1) PL204750B1 (pl)
WO (1) WO2005092873A2 (pl)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2853722A1 (en) 2011-10-27 2013-05-02 Mayo Foundation For Medical Education And Research Inhibiting g protein coupled receptor 6 kinase polypeptides
US20170050939A1 (en) * 2014-04-21 2017-02-23 Mayo Foundation For Medical Education And Research Small molecule inhibitors of g protein coupled receptor 6 kinase polypeptides
US9902739B2 (en) 2014-04-21 2018-02-27 Mayo Foundation For Medical Education And Research Small molecule inhibitors of G protein coupled receptor 6 kinases polypeptides
CN109251188A (zh) * 2018-09-26 2019-01-22 河北工业大学 一种2-甲基氨基-5-叔丁基-1,3,4-噻二唑的制备方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9725055D0 (en) * 1997-11-26 1998-01-28 Pharmacia & Upjohn Spa 1,3,4-thiadiazoles compounds

Also Published As

Publication number Publication date
WO2005092873A2 (en) 2005-10-06
WO2005092873A3 (en) 2006-03-16
PL204750B1 (pl) 2010-02-26

Similar Documents

Publication Publication Date Title
IL176296A0 (en) Method for the production of an administration form which is secured against misuse
IL227841A0 (en) Dihydropyridinones for the treatment of cancer
HK1107821A1 (en) Method for the production of dihydropteridinones
EP1706112A4 (en) METHODS FOR TREATING INFLAMMATORY DISEASE
HK1101587A1 (en) Method for the preparation of d-erythro-2,2-difluoro-2-deoxy-1-oxoribose derivative
GB0329874D0 (en) Compounds useful for the treatment of diseases
EP1611120A4 (en) NEW M THODES FOR THE TREATMENT OF INFLAMMATORY DISEASES
PL366644A1 (pl) Nowy związek, zastosowanie nowego związku w leczeniu chorób neurologicznych oraz sposób otrzymywania nowego związku
GB0400802D0 (en) Compounds for the treatment of disease
GB0501129D0 (en) Method of treatment by administration of RNA
ZA200606780B (en) Compounds for the treatment of diseases
IL178960A0 (en) Process for the preparation of pyridin-2-ylmethylsulphinyl-1h-benzimidazol compounds
HUP0401379A2 (en) Process for the preparation of risperidon
PL369391A1 (pl) Sposób wytwarzania środka dezynfekującego oraz środek dezynfekujący
GB0420867D0 (en) Compounds for the treatment of diseases
IL177531A0 (en) Compounds for the treatment of diseases
GB0425073D0 (en) Compounds for the treatment of diseases
AP2006003743A0 (en) Compounds useful for the treatment of diseases
GB0425064D0 (en) Compounds useful for the treatment of diseases
PL366493A1 (pl) Sposób wytwarzania S-(-)-1,2,3,4-tetrahydro-2-naftolu
PL370009A1 (pl) Sposób wytwarzania S-(-)-1,2,3,4-tetrahydro-2-naftolu
PL369395A1 (pl) Sposób wytwarzania trumien papierowo-tekturowych
PL366643A1 (pl) Nowy związek, zastosowanie nowego związku jako czynnika antynowotworowego oraz sposób otrzymywania nowego związku
PL369884A1 (pl) Sposób wytwarzania podstawionych cyjanowinylooksiranów
PL372016A1 (pl) Sposób wytwarzania pochodnych N-fenylo-2-pirymidynoamin